2006
DOI: 10.1016/j.rmed.2005.10.026
|View full text |Cite
|
Sign up to set email alerts
|

Survival of biphasic pulmonary blastoma

Abstract: Pulmonary blastoma is a rare malignant lung tumor with a poor prognosis. It is composed of immature mesenchymal and epithelial components that resemble fetal lung tissue. We aimed to share our treatment results in biphasic pulmonary blastoma. In Ataturk Chest Disease and Thoracic Surgery Center, five patients with biphasic pulmonary blastoma (four men, one woman, aged between 27 and 61-mean 39.4) were treated between 1987 and 2000 (0.3% of operated NSCC). Hemoptysis, cough, chest pain and dyspnea were the symp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(31 citation statements)
references
References 15 publications
0
30
0
1
Order By: Relevance
“…Koss et al [8], reported a mean survival of 33 months in 66 resected cases compared to 2 months in 17 patients with unresected disease. Liman et al [9], reported that resection of small tumors which do not have any lymph node involvement can provide better survival without any additional treatment. Limited resections do better than pneumonectomies, but wedge resection should be avoided.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Koss et al [8], reported a mean survival of 33 months in 66 resected cases compared to 2 months in 17 patients with unresected disease. Liman et al [9], reported that resection of small tumors which do not have any lymph node involvement can provide better survival without any additional treatment. Limited resections do better than pneumonectomies, but wedge resection should be avoided.…”
Section: Discussionmentioning
confidence: 99%
“…Unfortunately, 43% of tumors recur within 1 year with a propensity for sites such as brain and Mediastinum [8]. Recurrence tends to occur within 1 year after diagnosis or not at all [9].…”
Section: Discussionmentioning
confidence: 99%
“…The prognosis reported in the literature is generally poor, with limited survival within 2-3 years from diagnosis. The difference in survival rate depends on mediastinal node involvement and over the last ten years a better prognosis has been shown with preoperative neoadjuvant chemotherapy [14,16] . In a case of N2 disease, postoperative adjuvant radiation therapy and chemotherapy based on cisplatin and etoposide are considered the treatments of choice [14,17,18] .…”
Section: Discussionmentioning
confidence: 99%
“…Distant metastases are frequent in the liver, brain and bone. It is known very little about the physiology of this tumor [27]. This is the first work that describes the establishment and the phenotypic characteristics of a cell line of human pulmonary blastoma.…”
Section: Discussionmentioning
confidence: 99%